Photodynamic Therapy and Immunity: An Update†
DOI 10.1007/s00262-014-1633-9
Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease
J. Clin. Med. 2020, 9, 333; doi:10.3390/jcm9020333
Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical Recommendations
Theranostics 2021, Vol. 11, Issue 11
Turning cold tumors into hot tumors by improvingT-cell infiltration
DOI 10.1002/lsm.20513
Long-Term Survival of Patients Treated With Photodynamic Therapy for Carcinoma In Situ and Early Non-Small-Cell Lung Carcinoma
DOI: 10.1371/journal.pone.0133230
Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread
DOI: 10.1200/JCO.1993.11.10.1852
A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group
DOI: 10.1200/JCO.2004.07.097
Phase II Trial of Pleural Photodynamic Therapy and Surgery for Patients With Non–Small-Cell Lung Cancer With Pleural Spread
DOI: 10.1513/AnnalsATS.201509-650FR
Photodynamic Therapy of Non–Small Cell Lung Cancer- Narrative Review and Future Directions